BURLINGTON, Mass., July 12, 2018 /PRNewswire/ -- Decision Resources Group (DRG), a premier provider of high-value healthcare data, analytics, and insights products and services today announced it is a winner of the 2018 Best Vendor Partners in Biopharma presented by TGaS® Advisors, a benchmarking and advisory services firm for commercial organizations in the life sciences industry.

"While the life sciences industry continues to advance meaningful innovation, a critical component of its successful commercial strategy remains balancing sustainable access and optimizing access to these innovations," says Brian Corvino, Senior Vice President at DRG Market Access. "We are dedicated to this important mission and are both humbled and proud to have been recognized by the biopharmaceutical industry as the leading partner in helping companies navigate the market access environment."

TGaS invited pharmaceutical companies to nominate their best vendor partners and Decision Resources Group was identified as the best in the area of Market Access & Reimbursement. DRG provides enterprise-level market access solutions, offering a single source of truth for market access data, meaningful insights to keep teams up to date with local markets, and consulting services to help solve for complex market access challenges.

"This achievement provides DRG with the distinct privilege of being recognized by the biopharma industry as a Best Vendor Partner in the area of Market Access & Reimbursement," says Gary McWalters, President of TGaS. "The TGaS award demonstrates that DRG has been identified by pharmaceutical companies as one of the best business partners to align with clients to meet their goals."

DRG met criteria in four key areas for the award as a partner that aligns, plans, and executes to outcomes as well as provides overall satisfaction to its pharmaceutical clients.

"This award spotlights Decision Resources Group's collaborative approach to ensure our clients have the best information and access to our knowledgeable analyst teams," says Jeff Forringer, Senior Vice President at DRG Market Access. "Our unique client approach resulted in positive feedback from the biopharmaceutical companies that nominated DRG as a Best Vendor Partner."

DRG's market access solutions leverage unparalleled data assets, analytics, insights and consulting services, to help life sciences clients address evolving issues of balancing access and innovation, from pre-launch to product maturity.

Visit  https://decisionresourcesgroup.com/market-access/  to contact us or learn more about DRG's market access solutions.

About Decision Resources Group

DRG, a subsidiary of Piramal Enterprises Ltd., is the premier source for global healthcare data and market intelligence. A trusted partner for over 20 years, DRG helps companies competing in the global healthcare industry make informed business decisions. Organizations committed to developing and delivering life-changing therapies to patients rely on DRG's in-house team of expert healthcare analysts, data scientists, and consultants for critical guidance. DRG products and services, built on extensive data assets and delivered by experts, empower organizations to succeed in complex healthcare markets.

To learn more, visit www.decisionresourcesgroup.com.

Media contact: Penelope Williams, +1-617-747-9090, pwilliams@teamdrg.com

Decision Resources Group Logo. (PRNewsFoto/Decision Resources Group)

SOURCE Decision Resources Group

As Amazon enters drug distribution, patients and physicians are hopeful for healthcare disruption

View Now